authors
- Lee, AYY
- Julian, James
- Levine, Mark Norman
- Baker, RI
- Bowden, C
- Kakkar, AK
- Prins, M
- Rickles, FR
- Gent, M
Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE)
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 2003
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)